Find similar content

Source channel @githubtrending · Post #14915 · Jul 5

#other#awesome_list#brasil#ciencia_da_computacao#computer_science#curriculo#cursos#hacktoberfest The MIT License is a simple and permissive software license that lets you freely use, copy, modify, merge, publish, distribute, sublicense, and sell software, as long as you include the original copyright notice and license text in all copies. It does not require you to share your changes or make your code open source. The software is provided "as is," without any warranty, so the authors are not responsible for any problems. This license gives you great freedom and flexibility to use software for any purpose, including commercial, with minimal legal restrictions[1][3][5]. This benefits you by allowing easy and safe use and sharing of software without complex legal barriers. https://github.com/Universidade-Livre/ciencia-da-computacao

Hashtags

#other #awesome_list #brasil #ciencia_da_computacao #computer_science #curriculo #cursos #hacktoberfest

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment